The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism

Metabolism: Clinical and Experimental

Volumn 45, Issue 2, 1996, Pages 261-267

  St Amand, J ^b   Moorjani, S ^b   Lupien, P J ^b   Prud'homme, D ^b   Despres J P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029947523     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90064-5     Document Type: Article

References (67)

1. Eckel RH: Lipoprotein lipase: A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320:1060-1068, 1989
2. Wang C-S, Hartsuck J, McConathy WJ: Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta 1123:1-17, 1992
3. Magill P, Rao SN, Miller NE, et al: Relationships between the metabolism of high-density lipoprotein and very low-density lipoprotein in man: Studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest 12:113-120, 1982
4. Huttunen JK, Ehnholm C, Kekki M, et al: Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridemia: Correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med 50:249-260, 1976
5. Boberg J: Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia. Acta Med Scand 191:97-102, 1972
6. Pollare T, Vessby B, Lithell H: Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arteriosclerosis 11:1192-1203, 1991
7. Jackson RL, Yates MT, McNerney CA, et al: Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm Metab Res 22:289-294, 1990
8. 2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 75:4519-4523, 1978
9. Blades B, Vega GL, Grundy SM: Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arteriosclerosis 13:1227-1235, 1993
10. Nikkilä EA: Metabolic regulation of plasma high density lipoprotein concentrations. Eur J Clin Invest 8:111-113, 1978
11. 3 levels by lipoprotein lipase. Clin Chim Acta 112:325-332, 1981
12. Kekki M: Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis 37:143-150, 1980
13. Pouliot M-C, Després J-P, Moorjani S, et al: Regional variation in adipose tissue lipoprotein lipase activity: Association with plasma high density lipoprotein levels. Eur J Clin Invest 21:398-405, 1991
14. Glaser DS, Yost TJ, Eckel RH: Preheparin lipoprotein lipolytic activities: Relationship to plasma lipoproteins and postheparin lipolytic activities. J Lipid Res 33:209-214, 1992
15. Kuusi T, Kesäniemi A, Vuoristo M, et al: Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 7:421-425, 1987
16. Kuusi T, Ehnholm C, Viikari J, et al: Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 30:1117-1126, 1989
17. Taskinen MR, Glueck CJ, Kashyap ML, et al: Post-heparin plasma lipoprotein and hepatic lipase: Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and normal subjects. Atherosclerosis 37:247-256, 1980
18. 2 cholesterol. Arteriosclerosis 5:273-282, 1985
19. St-Amand J, Després J-P, Lemieux S, et al: Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women? Metabolism 44:491-498, 1995
20. Ehnholm C, Huttunen JK, Kinnunen PJ, et al: Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase AI of human postheparin plasma. N Engl J Med 292:1314-1317, 1975
21. Peltonen P, Marniemi J, Hietanen E, et al: Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: A longitudinal study. Metabolism 30:518-526, 1981
22. 3 and postheparin plasma lipases in relation to parameters of physical fitness. Atherosclerosis 41:209-219, 1982
23. Després J-P, Ferland M, Moorjani S, et al: Role of hepatictriglyceride lipase activity in the association between intraabdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 9:485-492, 1989
24. Kostner GM, Laggner P: Chemical and physical properties of lipoproteins, in Curtius H-C, Roth M (eds): Human Plasma Lipoproteins. New York, NY, de Gruyter, 1989, pp 23-54
25. Mahley RW, Innerarity TL: Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737:197-222, 1983
26. Utermann G, Jaeschke M, Menzel M: Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett 56:352-355, 1975
27. Zannis VI, Breslow JL, Utermann G, et al: Proposed nomenclature of apoE isoproteins, apoE genotype, and phenotypes. J Lipid Res 23:911-914, 1982
28. Weisgraber KH: Apolipoprotein E: Structure-function relationships. Adv Protein Chem 45:249-302, 1994
29. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21, 1988
30. Utermann G, Kindermann I, Kaffarnik H, et al: Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 65:232-236, 1984
31. Weintraub MS, Eisenberg S, Breslow JL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80:1571-1577, 1987
32. Lamarche B, Després J-P, Pouliot M-C, et al: Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arteriosclerosis 13:33-40, 1993
33. Siri WE: The gross composition of the body. Adv Biol Med Phys 4:239-280, 1956
34. Meneely GR, Kaltreider NL: Volume of the lung determined by helium dilution. J Clin Invest 28:129-139, 1949
35. Lohman T, Roche A, Martorel R (eds): The Airlie (VA) Consensus Conference: Standardization of Anthropometric Measurements. Champaign, IL, Human Kinetics, 1988, pp 39-80
36. Havel RJ, Eder H, Bragdon HF: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
37. Burstein M, Samaille J: Sur un dosage rapide du cholesterol lié aux α- et β-lipoprotéines du sérum. Clin Chim Acta 5:609, 1960
38. Pouliot M-C, Després J-P, Nadeau A, et al: Visceral obesity in men: Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
39. Gidez LI, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
40. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45-52, 1966
41. Moorjani S, Dupont A, Labrie F, et al: Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250, 1987
42. Bouthillier D, Sing CF, Davignon J: Apolipoprotein E phenotyping with a single gel method: Application to the study of informative matings. J Lipid Res 24:1060-1069, 1983
43. Moorjani S, Gaudet D, Laberge C, et al: Hypertriglyceridemia and lower LDL cholesterol concentration in relation to apolipoprotein E phenotypes in myotonic dystrophy. Can J Neurol Sci 16:129-133, 1989
44. Malik N, Berrie A: New stain fixative for proteins separated by gel isoelectric focusing based on Coomassie brillant blue. Anal Biochem 49:173-176, 1972
45. Nilsson-Ehle P, Ekman R: Specific assays for lipoprotein lipase and hepatic lipase activities of post-heparin plasma, in Peeters H (ed): Protides and Biological Fluids. Oxford, UK, Pergamon, 1978, pp 243-246
46. Nilsson-Ehle P: Measurements of lipoprotein lipase activity, in Borensztajn J (ed): Lipoprotein Lipase. Chicago, IL, Evener, 1987, pp 59-77
47. Gaudet D, Moorjani S, Gagné C, et al: Premature coronary artery disease and high prevalence of monogenic traits for lipid disorders among French Canadians in a north eastern region of Québec province. Atherosclerosis 109:203, 1994 (abstr)
48. Gregg RE, Brewer HB: The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. Clin Chem 34:B28-B32, 1988
49. Dallongeville J, Lussier-Cacan S, Davignon J: Modulation of triglyceride levels by apoE phenotype: A meta-analysis. J Lipid Res 33:447-454, 1992
50. Ferrell RE, Kamboh MI: Interaction of apolipoprotein E genotype and dietary cholesterol in determining plasma cholesterol levels. Am J Hum Genet 50:236, 1992
51. Boerwinkle E, Visvikis S, Welsh D, et al: The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 27:567-582, 1987
52. Kaprio J, Ferrell RE, Kottke BA, et al: Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arteriosclerosis 11:1330-1348, 1991
53. Hegele RA, Breckenridge WC, Cox DW, et al: Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations. Arteriosclerosis 11:1303-1309, 1991
54. Miettinen TA: Impact of apo E phenotype on the regulation of cholesterol metabolism. Ann Med 23:181-186, 1991
55. Pouliot M-C, Després J-P, Moorjani S, et al: Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 31:1023-1029, 1990
56. Després J-P, Moorjani S, Lupien PJ, et al: Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 113:151-169, 1992
57. Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 2:1261, 1988
58. Watanabe MEK, Iwashima Y, Morikawa A, et al: Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes 35:1374-1382, 1986
59. Eichner JE, Ferrell RE, Kamboh MI, et al: The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: The Pittsburg Epidemiology of Diabetes Complications Study IX. Metabolism 41:347-351, 1992
60. Havel RJ: Role of apolipoprotein E in lippoprotein metabolism. Am Heart J 113:470-474, 1987
61. Utermann G, Vogelberg KH, Steinmetz A, et al: Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet 15:37-62, 1979
62. Utermann G: Apolipoprotein E polymorphism in health and disease. Am Heart J 113:433-440, 1987
63. Mann WA, Meyer N, Weber W, et al: Lipoprotein lipase can compensate for the defective function of apolipoprotein E variants in lipoprotein binding to cells. Atherosclerosis 109:262, 1994 (abstr)
64. Sehayek E, Lewin-Velvert U, Chayek-Shaul T, et al: Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein. J Clin Invest 88:553-560, 1991
65. Evans AJ, Sawyez CG, Wolfe BM, et al: Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. J Biol Chem 267:10743-10751, 1992
66. 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. J Biol Chem 268:14168-14175, 1993
67. Herz J: The LDL-receptor-related protein: Portrait of a multifunctional receptor. Curr Opin Lipidol 4:107-113, 1993